Abide Therapeutics Names New COO

Abide Therapeutics – headquartered in San Diego — has a new chief operating officer: Kevin Finney.

Tease photo

ResMed Reports Second Quarter Results

San Diego’s ResMed posted quarterly earnings of 86 cents per share, with adjusted earnings of $1 per share.

LunaPBC to Merge Platform with Genetic Alliance

LunaPBC — a Solana Beach startup that in December launched a first-of-its-kind platform that gives shares for contributing DNA data — is joining forces with a like-minded nonprofit.

Gossamer Finds a Way Around Government Shutdown for IPO

Gossamer Bio will take an alternative path to going public on account of the government shutdown stalling initial public offerings, per a Jan. 23 filing.

Tease photo

New Chief of Staff Named at Scripps Mercy Hospital

Dr. Megan Hamreus now leads a 1,100-member physician team at Scripps Mercy Hospital’s two medical campuses.

San Diego Businesses Found Lacking in Female Board Members

Under a new law, California public companies must have at least one woman on their board by the end of 2019. It appears the biggest impact will be in San Diego.

Tease photo

Mirati Shines at Healthcare Conference

At the annual J.P. Morgan Healthcare conference, major San Diego players like Illumina naturally command attention. But quietly, Mirati Therapeutics had a strong showing.

Public-Private Partnership Helps Fund Superbug Fight

Forge Therapeutics recently took in more funding — up to $11.1 million — to battle life-threatening infections called “superbugs.”

Tease photo

Retrophin Names New CEO

Earlier this month San Diego-based Retrophin’s board appointed a new president and CEO: Eric Dube.

Ligand’s Stock Falls as Analysts Debate Value

PHARMA: Co. Confident in Revenue, Cash and Portfolio

Ligand Pharmaceutical’s stock has lost more than half of its value since October, puzzling the company and most analysts, though a vocal minority are skeptical of the company’s pipeline.

Tease photo

Jan Caldwell Becomes Chairman of Scripps Health Board

Jan Caldwell, who has sat on Scripps Health’s board since 2012, was named board chairman, it was announced Jan. 14.

Cirius Therapeutics Outlines $86M IPO Plans

Liver drug developer Cirius Therapeutics on Jan. 11 put in a prospectus for an $86 million initial public offering.

State’s First Accredited Senior Emergency Department Opens in San Diego

UC San Diego Health has opened a new senior emergency department, complete with a team trained in geriatric medicine and senior-friendly architectural design.

Government Shutdown Puts Brakes on IPO Plans

The federal government shutdown has stalled San Diego biotechs knocking on the door of an initial public offering.

Salk Board Gives Interim President a Five Year Term

The Salk Institute’s board recently voted to give President Rusty Gage a five-year job extension.